WKinThought

in_Thought

United States, EnglishHealth

An active primary research team delivering forward-looking analyses to healthcare professionals as well as to institutional investors.

On-Demand Episodes

  • by WKinThought
  • in Health
  • on
An original inThought Expert Discussion Series archive recording from 21st April, 2011. Speaking for the inThought Expert Discussion series on "The Exciting Potential of OrthoBiologics" is William J. Maloney, M.D, Professor and Chairman... more

  • by WKinThought
  • in Health
  • on
An original inThought Expert Discussion Series archive recording from 8th March, 2011. Speaking for the inThought Expert Discussion series on "Clinical Trial Designs: PLX4032’s BRIM3 Trial and Other Tribulations" is Andrew J. Vickers,... more

  • by WKinThought
  • in Health
  • on
An original inThought Expert Discussion Series archive recording from 23rd February, 2011. Speaking for the inThought Expert Discussion series on "Will Benlysta change the Lupus landscape?" is Dr George Tsokos, Professor of... more

  • by WKinThought
  • in Health
  • on
An original inThought Expert Discussion Series archive recording from 26th January, 2011. Speaking for the inThought Expert Discussion series on Personalized Medicine: Emerging Trends in Molecular Diagnostics is Edward D.... more

  • by WKinThought
  • in Health
  • on
An original inThought Expert Discussion Series archive recording from 25th January, 2011. Speaking for the inThought Expert Discussion series on Personalized Antiplatelet Medicine is Paul A. Gurbel, MD, FACC joining our Snr... more

  • by WKinThought
  • in Health
  • on
An original inThought Expert Discussion Series archive recording from 18th November, 2010. Speaking for the inThought Expert Discussion series on Where does Gilenya fit in the treatment of Multiple Sclerosis? is Dr Bruce Cree, MD,... more

  • by WKinThought
  • in Health
  • on
An original inThought Expert Discussion Series archive recording from 19th October, 2010. Speaking for the inThought Expert Discussion series on Anti-Angiogenic and Vascular Targeting Agents for Cancer Therapy is Philip E.... more

  • by WKinThought
  • in Health
  • on
An original inThought Expert Discussion Series archive recording from 23rd September, 2010. Speaking for the inThought Expert Discussion series on Hot Topics at TCT2010 is Dr Rohit Arora from the Chicago Medical School... more

  • by WKinThought
  • in Health
  • on
An original inThought Expert Discussion Series archive recording from 18th August, 2010. Speaking for the inThought Expert Discussion series on Biosimilars: Next Steps is Janice M. Reichert, PhD - Senior Research Fellow at Tufts Center... more

  • by WKinThought
  • in Health
  • on
An original inThought Expert Discussion Series archive recording from 31st March, 2010. SGLT2 inhibitors are a promising class of antidiabetes drugs that have the potential to be complementary to all existing diabetes therapies,... more
 comments

Learn More Create and Share Get Support Follow Us
BlogTalkRadio is the easiest way to create and share audio on the web.

cinchcast
© 2012 BlogTalkRadio.com. All Rights Reserved.     Privacy Policy Terms of Use Revenue Sharing
Help